Current Report Filing (8-k)
15 Julho 2022 - 11:43AM
Edgar (US Regulatory)
0001676047
false
0001676047
2022-07-13
2022-07-13
0001676047
us-gaap:CommonStockMember
2022-07-13
2022-07-13
0001676047
NTRB:WarrantsMember
2022-07-13
2022-07-13
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
July 13, 2022
Nutriband Inc.
Nevada |
|
000-55654 |
|
81-1118176 |
(State or Other Jurisdiction
of Incorporation) |
|
(Commission File Number) |
|
(I.R.S. Employer
Identification No.) |
121 S. Orange Ave. Suite 1500
Orlando, Florida |
|
32801 |
(Address of Principal Executive Offices) |
|
(Zip Code) |
(407) 377-6695
Registrant’s Telephone Number, Including
Area Code
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ☒
Securities registered pursuant to Section 12(b)
of the Act:
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
Common Stock |
|
NTRB |
|
The Nasdaq Stock Market LLC |
Warrants |
|
NTRBW |
|
The Nasdaq Stock Market LLC |
Item 7.01. Regulation FD Disclosure.
The Company received a favorable verdict on July 13, 2022 from the Circuit
Court, Orange County, Florida, providing for rescission of the Company’s 2017 acquisition of Advanced Health Brands and recovery
by the Company of the 1,200,000 shares of common stock issued in the acquisition.
See Press Release attached as Exhibit 99.1.
Item 9.01 Financial
Statements and Exhibits
(d) Exhibits
The following exhibits are being filed with this Current Report on
Form 8-K:
SIGNATURES
PURSUANT TO THE REQUIREMENTS OF THE SECURITIES
EXCHANGE ACT OF 1934, THE REGISTRANT HAS DULY CAUSED THIS REPORT TO BE SIGNED ON ITS BEHALF BY THE UNDERSIGNED THEREUNTO DULY AUTHORIZED.
|
NUTRIBAND, INC. |
|
|
|
Date: July 15, 2022 |
By: |
/s/ Gareth Sheridan |
|
R: Gareth Sheridan |
|
Chief Executive Officer |
2
Nutriband (NASDAQ:NTRB)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Nutriband (NASDAQ:NTRB)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025